Stock Rich List
#1162 on the rich list of 14,644 insiders

John L. Higgins

Director at Ligand Pharmaceuticals; Director at OmniAb; Director at Bio-Techne. Based in Minneapolis, Minnesota.

$141M
in disclosed stock, −$5.1M (−3.48%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1162nd of 14,644
Companies held
3
Largest holding
LGND, 85.3% of total
Latest SEC filing
Oct 29, 2026

What the $141M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Ligand Pharmaceuticals LGND
Common Stock
Directly417,695$286.94$120M85.3%Form 4, Dec 28, 2022
OmniAb OABI
Common Stock
Directly2,962,320$5.03$14.9M10.6%Form 4, Jun 17, 2026
Bio-Techne TECH
Common Stock
Directly80,004$72.70$5.8M4.1%Form 4, Oct 29, 2026

Share counts are the amounts John L. Higgins reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 7, 2025BoughtOABI41,038$1.38$57KView
Nov 6, 2025BoughtOABI36,223$1.41$51KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1159John Kristofer Galashan
Director, Life Time Group Holdings. Los Angeles, CA
$141M−$4.7M (−3.22%)
1160Travis Murdoch
CEO and President, Braveheart Bio. San Francisco, CA
$141M+$5.4M (+3.99%)
1161David R. Pelizzon
Director, OrthoPediatrics. Granby, CT
$141M+$1.8M (+1.30%)
1162John L. Higgins
Director, Ligand Pharmaceuticals. Minneapolis, MN
$141M−$5.1M (−3.48%)
1163Ramin Kamfar
Director, Bluerock Private Real Estate Fund. New York, NY
$140M−$1.0M (−0.73%)
1164Kenneth S. Courtis
Director, Alpha Metallurgical Resources. Bristol, TN
$140M−$6.2M (−4.24%)
1165David V. Auld
Executive Chairman, D.R. Horton. Arlington, TX
$140M−$1.7M (−1.21%)

Other Ligand Pharmaceuticals insiders

All LGND insiders

Questions

How much stock does John L. Higgins own?

John L. Higgins holds $140,570,164 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 1162nd on the Stock Rich List.

Is this John L. Higgins's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did John L. Higgins last buy or sell stock?

The most recent open-market trade on file is a purchase of 41,038 OABI shares on Nov 7, 2025 at $1.38.